Purpose of the Test
- Early prediction of preeclampsia risk before clinical symptoms appear.
- Assessment of placental efficiency and fetal blood flow.
- Assisting doctors in determining the need for hospitalization or close monitoring.
Book sFlt-1/PlGF Ratio Test in Saudi Arabia | Lahalak Medical Platform
Protect yourself from sudden preeclampsia risks. This advanced screening predicts the likelihood of preeclampsia with high accuracy before symptoms appear, ensuring timely medical intervention for you and your baby's safety.
Scientific name: sFlt-1/PlGF Ratio for Preeclampsia Prediction
An advanced blood test measuring the balance between sFlt-1 and PlGF proteins to assess placental health. It predicts preeclampsia risk in the coming weeks, enabling precise preventative medical decisions.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- sFlt-1 protein measurement
- PlGF protein measurement
- Risk ratio calculation
Medical Service Information
Target Groups
- Pregnant women with existing hypertension.
- Women with a prior history of preeclampsia.
- Pregnant women experiencing symptoms like severe headache or limb swelling.
Clinical Significance
- A low ratio rules out preeclampsia for the next week with approximately 99% accuracy.
- A high ratio indicates an imminent risk requiring preventive medical intervention.
Conditions & Notices
- Preferably performed between weeks 20 and 37 of pregnancy
- Inform the lab of any blood pressure medications being taken
Medical services you might also like
